首页> 外文期刊>The Japanese journal of antibiotics >Effectiveness of current and repeated vaccinatio with quadrivalent influenza vaccine during the 2017/18 season in Japan
【24h】

Effectiveness of current and repeated vaccinatio with quadrivalent influenza vaccine during the 2017/18 season in Japan

机译:日本2017/18赛季中二价流感疫苗的当前和重复疫苗的有效性

获取原文
获取原文并翻译 | 示例
           

摘要

The effectiveness of repeated vaccination of the quadrivalent influenza vaccine is currently unknown. This study aims to estimate current and repeated vaccination effectiveness (VE) of the quadrivalent influenza vaccine. A test-negative case-control study was performed during the 2017-2018 season. The participants were Japanese children divided into four groups (6-11 months and ages 1-5, 6-12, and 13-15 years). Current VE: Overall, the adjusted VE was significant for influenza B (36.4; 95% confidence interval [CI]: 9.8-55.2); the adjusted VE was significant for any influenza (A+B; 47.3%; 95% CI: 12.2-68.3) and influenza B (56.2%; 95% CI: 17.9-76.6) only in the1-5 year age group. In other groups, VE was not observed. Vaccine doses: Two vaccine doses significantly decreased the incidence of any influenza and influenza B compared to no vaccination or only one dose in only the 1-5 year old group. Repeated VE: The adjusted VE was significant for any influenza (72.6%; 95% CI: 27.1-89.7) and influenza B (69.7%; 95% CI: 4.5-90.4) in only the 1—5-year age group without vaccination in the previous season. It was also significant for influenza B (68.6%; 95% CI: 1.3-90.0) in the 6-12-year age group with two vaccination doses in the previous season. In other groups, repeated VE was not observed for any influenza types. The reason for that repeated VE may depend on age, repeated vaccination with two doses may be valuable in the 6-12 year age group, although current VE was not observed.
机译:反复疫苗接种的四级流感疫苗的有效性目前未知。本研究旨在估算四肢甲型流感疫苗的电流和反复疫苗接种效果(VE)。在2017-2018季节进行了测试负案例对照研究。参与者是日本儿童分为四组(6-11个月,1-5岁,6-12和13-15岁)。目前的VE:总体而言,调节的VE对流感B的显着性(36.4; 95%置信区间[CI]:9.8-55.2);对于任何流感(A + B; 47.3%; 95%CI:12.2-68.3)和流感B(56.2%; 95%CI:17.9-76.6),调整后的VE非常显着。在其他群体中,没有观察到。疫苗剂量:两种疫苗剂量明显降低了任何流感和流感B的发病率,而不是在1-5岁的群体中只有一种剂量或仅一次剂量。重复ve:调整后的VE对任何流感(72.6%; 95%CI:27.1-89.7)和流感B(69.7%; 95%CI:4.5-90.4)只有1-5岁的年龄组而没有接种疫苗在前赛季。在6-12岁的年龄组中,流感B(68.6%; 95%CI:1.3-90.0)也是显着的。前赛季中有两种疫苗接种剂量。在其他群体中,没有针对任何流感类型观察到重复的VE。重复ve的原因可能依赖于年龄,在6-12岁年龄组中,两种剂量的重复疫苗接种可能是有价值的,尽管目前的VE没有观察到。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号